Kris Motmans
Directeur/Membre du Conseil chez SEPS Pharma NV
Provenance du réseau au premier degré de Kris Motmans
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Apitope Technology (Bristol) Ltd.
 Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
SEPS Pharma NV
 SEPS Pharma NV Pharmaceuticals: GenericHealth Technology SEPS Pharma NV provides controlled drug delivery and develops self emulsifying pro drug systems. Its services include preformulation, formulation development and analytical development. The company was founded on October 19, 2007 and is headquartered in Diepenbeek, Belgium.
4
| Subsidiary | Pharmaceuticals: Generic | 4 |
Medinvents NV
 Medinvents NV Medical SpecialtiesHealth Technology Medinvents NV engages in the manufacture of biopsy surgical instruments. The company was founded on December 28, 1992 and is headquartered in Hasselt, Belgium.
3
| Private Company | Medical Specialties | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Kris Motmans via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Apitope International NV
 Apitope International NV BiotechnologyHealth Technology Apitope International NV develops therapeutic vaccines. It operates as a bio-pharmaceutical company that engages in developing peptide therapies. The firm specializes on the discovery and development of revolutionary disease modifying therapies for treating autoimmune and allergic diseases, including multiple sclerosis, and Graves’ disease, FVIII intolerance and uveitis. The company was founded by David Wraith in 2002 and is headquartered in Diepenbeek, Belgium. | Biotechnology | Director/Board Member Chairman Founder Chairman Chief Executive Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Operating Officer | |
| TIGENIX NV | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Université Catholique de Louvain | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Fast Forward Pharmaceuticals BV
 Fast Forward Pharmaceuticals BV Medical SpecialtiesHealth Technology Fast Forward Pharmaceuticals BV develops novel disease-modifying therapeutics for the treatment of inflammatory and autoimmune diseases. It is developing an anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The company was founded by Louis Boon in October 2010 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member Director/Board Member | |
Biotechnological Enzymatic Catalyse NV
 Biotechnological Enzymatic Catalyse NV Food: Major DiversifiedConsumer Non-Durables Biotechnological Enzymatic Catalyse NV develops, produces and commercializes enzymatic systems for food preservation. It engages in the research, development and manufacturing of antimicrobial products for food safety. The firm's solutions are designed for use in the following: dairy products, fruit and vegetable juices, sauces and dressings and liquid egg products. The company was founded in 1992 and is headquartered in Ghent, Belgium. | Food: Major Diversified | Director/Board Member Director/Board Member | |
Vesalius Biocapital Partners SARL
 Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg. | Investment Managers | Founder Private Equity Investor | |
| Vesalius Biocapital II Partners SARL | Corporate Officer/Principal Founder | ||
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
Newton Biocapital Partners SRL
 Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre. | Investment Managers | Founder | |
Life Sciences, Inc.
 Life Sciences, Inc. Medical SpecialtiesHealth Technology Life Sciences, Inc. is a private company that is committed to saving lives and futures by providing superior products and services for scientific research. The company is based in St. Petersburg, FL. The company's offerings include AMV-RT, T7 RNA Polymerase, RNase H, NASBA, Lyophilized Products, and Services. The company was founded by Roderick N. Carter. | Medical Specialties | Director/Board Member | |
| Syntra Limburg | Corporate Officer/Principal | ||
Unizone Co., Ltd.
 Unizone Co., Ltd. Industrial SpecialtiesProcess Industries Unizone Co., Ltd. is a Japanese company that was founded in 1955 and engages in the processing of electroplating and electroless nickel plating. The company is based in Toyama, Japan. | Industrial Specialties | Corporate Officer/Principal | |
I.C. System, Inc.
 I.C. System, Inc. Miscellaneous Commercial ServicesCommercial Services I.C. System, Inc. provides accounts receivable management services. The firm serves the healthcare, consumer, commercial, financial, utilities, retail, government, education and telecommunication sectors. The company was founded by Ruth Erickson and Jack Erickson in 1938 and is headquartered in St. Paul, MN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Olivetti UK Ltd.
 Olivetti UK Ltd. Computer Processing HardwareElectronic Technology Part of ION Investment Group Ltd., Olivetti UK Ltd. is a company that specializes in the sale and maintenance of information processing systems, office products, and software. The company is based in Milton Keynes, UK. | Computer Processing Hardware | Corporate Officer/Principal | |
BTG, Inc.
 BTG, Inc. Information Technology ServicesTechnology Services BTG, Inc. provides information systems and technical services to government and commercial enterprises. The company was founded in 1982 and is headquartered in Fairfax, VA. | Information Technology Services | Corporate Officer/Principal | |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Founder | |
| University of Bristol | College/University | Corporate Officer/Principal | |
Ncardia Holding SA
 Ncardia Holding SA BiotechnologyHealth Technology Ncardia Holding SA provides biotech research and development, business management consulting, technical testing, and administrative services. The private company is based in Mont-Saint-Guibert, Belgium. The Belgian company was founded in 2014. Stefan Braam has been the CEO of the company since 2015. | Biotechnology | Director/Board Member | |
| Xios Hogeschool | Corporate Officer/Principal | ||
Cellaïon SA
 Cellaïon SA BiotechnologyHealth Technology Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| A Q Invest SRL | Corporate Officer/Principal | ||
| AQ Partners SRL | Corporate Officer/Principal | ||
| Solvay Business School of Economics & Management | College/University | Undergraduate Degree | |
| ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member | |
Ncardia SA
 Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Bio-Sourcing SA
 Bio-Sourcing SA BiotechnologyHealth Technology Bio-Sourcing SA develops and markets biological drugs for veterinary use. The firm focuses on farm animal health and companion animal health. The company was founded by Bertrand Mérot in June 2011 and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ghent University | College/University | Doctorate Degree | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director of Finance/CFO | |
FTSE Group
 FTSE Group Investment Banks/BrokersFinance FTSE Group creates and manages stock indices. The firm provides indexing and analytic solutions. Its services are offered to pension funds, asset managers, ETF providers and investment banks for investment analysis, performance measurement, asset allocation and hedging. The company was founded by Mark Makepeace in 1995 and is headquartered in London, the United Kingdom. | Investment Banks/Brokers | Corporate Officer/Principal | |
Holzworth Holdings, Inc.
 Holzworth Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Holzworth Holdings, Inc. conducts health research and provides technical, professional, and consulting services. The company was founded on December 19, 1996 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chief Operating Officer | |
Janssen-Cilag International NV
 Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the company since 2009. | Biotechnology | Chief Tech/Sci/R&D Officer | |
NHS AG
 NHS AG Advertising/Marketing ServicesCommercial Services NHS AG is an advertising agency. | Advertising/Marketing Services | Corporate Officer/Principal | |
| Quintiles UK Ltd. | Corporate Officer/Principal | ||
V&V Invest BV /BE/
 V&V Invest BV /BE/ Real Estate DevelopmentFinance V&V Invest BV is a residential construction company based in Hasselt, Belgium. and has subsidiaries in Belgium. The Belgian company specializes in developing residential construction projects. | Real Estate Development | Director/Board Member | |
| Cube Management Co. | Corporate Officer/Principal | ||
| Andaz Partners | Corporate Officer/Principal | ||
| Hogeschool-Universiteit Brussel | College/University | Graduate Degree | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Life Sciences Development Campus NV
 Life Sciences Development Campus NV Miscellaneous Commercial ServicesCommercial Services Life Sciences Development Campus NV provides research and development services in the field of biomedical life sciences. The company is headquartered in Abis, BelGium. | Miscellaneous Commercial Services | Director/Board Member |
Statistiques
Internationale
| Belgique | 25 |
| Etats-Unis | 11 |
| Royaume-Uni | 9 |
| Pays-Bas | 3 |
| Luxembourg | 3 |
Sectorielle
| Health Technology | 18 |
| Commercial Services | 9 |
| Consumer Services | 7 |
| Finance | 6 |
| Electronic Technology | 3 |
Opérationnelle
| Director/Board Member | 76 |
| Corporate Officer/Principal | 40 |
| Founder | 10 |
| Chief Executive Officer | 9 |
| Graduate Degree | 9 |
Relations les plus connectées
- Bourse
- Insiders
- Kris Motmans
- Connexions Sociétés
